NEW TREATMENT APPROACHES TO PREVENT PREMATURE RUPTURE OF MEMBRANES IN PREGNANT WOMEN WITH VARICOSE DISEASE

Abstract

Aims: To investigate modern methods to prevent premature rupture of membranes by the use of chlorhexidine in pregnant women with varicose disease.

Methods: The data of 39 pregnant women with varicose disease, who delivered between 2014 and 2016 at Maternity Hospital No. 3, Zaporozhye were analyzed using SPSS software. Patients were divided in 3 groups according to their medical history, complications during pregnancy, childbirth and postpartum period. The 1st group consisted of 13 pregnant women who did not receive prenatal vaginal douching with chlorhexidine; the 2nd group consisted of 13 patients with varicose disease, who received douching of birth canal with vaginal suppositories with chlorhexidine 1 time per day for 10 days before their delivery, but did not undergo a rehabilitation at the sanatorium; and the 3rd group had 13 pregnant women who received sanatorium rehabilitation at ‘‘Veliki lug’’ during the II. trimester of their pregnancy with the course of 1 chlorhexidine suppository per day for 10 days before delivery.

Results:In the 1st group, the percentage of premature death was 61.5%; anemia and significant ultrasound markers were present in 46.2%; the percentage for the presence of hematometra was 38.5%; premature rupture of membranes, anomalies of labor and polyhydroamniosis were 30.8%; chorioamnionitis 15.4%; and intrauterine infection of fetus was 7.7%. In the 2nd group, anemia was present in 35%, 23.1% showed anomalies of labor; premature rupture of membranes, ultrasound markers, premature death, and hematometra were present in 15.4%. Whereas in the 3rd group, anemia and anomalies of labor were present in 15.4%, premature rupture of the membranes and premature death were present in 7.7% of the patients.

Conclusion: With its broad antibacterial and antiviral effect, chlorhexidine in antiseptic form was found to be beneficial and it is found to promote the restoration of the vaginal microflora.

Keywords

• Pregnancy,infection,membrane

References

1. 1. Aaron BC, Julian NR, Errol RN et al. Contemporary diagnosis and management of preterm premature rupture of membranes. Rev Obstet Gynecol 2008;1(1):11– 22.
2. 2. Mackeen AD, Seibel-Seamon J, Grimes-Dennis J et al. Tocolytics for preterm premature rupture of membranes. Cochrane Database Syst Rev 2011;5(10):CD007062.
3. 3. Cunningham F. Abnormal Labor. In: Cunningham F, Leveno KJ, Bloom SL et al, editors. Williams Obstetrics. New York: McGraw-Hill Education; 2014.
4. 4. Roman AS. Late Pregnancy Complication, section: premature rupture of membranes. In: Decherney AH, Nathan L, Laufer N, editors. Current Diagnosis & Treatment: Obstetrics & Gynecology. New York: McGraw-Hill Medical; 2013.
5. 5. Sarah N, Dan KK, Freddie B et al. Practice bulletins No. 139: premature rupture of membranes. Obstet Gynecol 2013;122(4):918-30.
6. 6. Nakubulwa S, Kaye DK, Bwanga F et al. Genital infections and risk of premature rupture of membranes in Mulago Hospital, Uganda: a case-control study. BMC Res Notes 2015;16(8):573.
7. 7. Beckmann C. Premature Rupture of Membranes. In: Beckmann CRB, Ling FW, Barzansky BM, editors. Obstetrics and Gynecology. Baltimore: Lippincott; 2010.p.13–6.
8. 8. World Health Organization. WHO guidelines on hand hygiene in health Care. WHO, 2009. Available from URL:http://www.who.int/gpsc/5may/tools/9789241597906/en/ (13 August 2012).

9. 9. McClure EM, Goldenberg RL, Brandes N et al. The use of chlorhexidine to reduce maternal and neonatal mortality and morbidity in low-resource settings. International Journal of Gynecology and Obstetrics 2007;97(2):89–94.
10. 10. World Health Organization. Model list of essential medicines for children, 3rd list. Geneva: WHO; March 2011.
11. 11. World Health Organization Expert Committee on Essential Medicines. The selection and use of essential medicines. Geneva: WHO; 2009.
12. 12. ZA Lupinskaya. Endothelium of blood vessels-the main regulator of local blood flow. Vest-nik KRSU 2003:34-7.
13. 13. Lutsenko NS, Evtereva IA. Sanatorium-and-spa treatment as a factor of optimizing the out-come of pregnancy. Zaporozhye Medical Journal 2006:91-4.
14. 14. Lutsenko NS, Gayday NV, Shapran NF. Ways to optimize hemodynamics in the fetoplacen-tal pool, as a factor in influencing the perinatal outcome. Porto Biomed J 2017;2(5):245.
15. 15. Makarov OV, Kozlov LV. Ways of preventing perinatal morbidity and mortality in preterm pregnancy. Women’s Health 2012;72:91-5.
16. 16. Goldenberg RL, McClure EM, Saleem S et al. Use of vaginally administered chlorhexidine during labor to improve pregnancy outcomes. Obstet Gynecol 2006;107(5):1139–46.
17. 17. Taha TE, Biggar R, Broadhead RL et al. Effect of cleansing the birth canal with antiseptic solution on maternal and newborn morbidity and mortality in Malawi: clinical trial. BMJ 1997;315:216–9.
18. 18. Bakr AF, Karkour T. Effect of predelivery vaginal antisepsis on maternal and neonatal morbidity and mortality in Egypt. J Womens Health 2005;14:496–501.
19. 19. L C Mullany, J M Tielsch, G L Darmstadt et al. Topical applications of chlorhexidine to the umbilical cord for prevention of omphalitis and neonatal mortality in southern Nepal: a communi-ty-based, cluster-randomised trial. The Lancet 2006;367(9514):910-8.
20. 20. Lumbiganon P, Thinkhamrop J, Thinkhamrop B et al. Vaginal chlorhexidine during labour for preventing maternal and neonatal infections (excluding Group B Streptococcal and HIV). Cochrane Database Syst Rev 2004;18(4):CD004070.
21. 21. Lumbiganon P, Thinkhamrop J, Thinkhamrop B et al. Vaginal chlorhexidine during labour for preventing maternal and neonatal infections (excluding Group B Streptococcal and HIV). Cochrane Database Syst Rev 2014;14(9):CD004070.
22. 22. Christensen KK, Christensen P, Dykes A et al. Chlorhexidine for the prevention of neonatal colonization with group B streptococci. I. In vitro effect of chlorhexidine on group B streptococ-ci. European Journal of Obstetrics & Gynecology and Reproductive Biology 1983;16:157-65.
23. 23. Stade B, Shah V, Ohlssen A. Vaginal chlorhexidine during labour to prevent early-onset neonatal group B streptococcal infection. Cochrane Database Syst Rev 2004;3:CD003520.
24. 24. Hemani ML, Lepor H. Skin preparation for the prevention of surgical site infection: which agent is best? Reviews in Urology 2009;11(4):190-5.
25. 25. Shubair M, Stanek R, White S et al. Effects of chlorhexidine gluconate douche on normal vaginal flora. Gynecol Obstet Invest 1992;34(4):229-33.